As indicated in Table 1, patient demographics (age< or >60, gender) and molecular characteristics of the tumor (MGMT promoter and P53 gene status), as well as resection degree and RPA prognostic factor, are not differently distributed (p > 0.05) between both subpopulations with low and high integrin α5 protein expression levels. The gene discussed is TP53; the disease is neoplasm.